true 2019-02-01 2020-01-31 false 05341925 uk-bus:Director1 2019-02-01 2020-01-31 05341925 uk-bus:Director2 2019-02-01 2020-01-31 05341925 2019-02-01 2020-01-31 05341925 2020-01-31 05341925 uk-bus:EntityHasNeverTraded 2019-02-01 2020-01-31 05341925 uk-bus:FRS102 2019-02-01 2020-01-31 05341925 uk-bus:FullAccounts 2019-02-01 2020-01-31 05341925 uk-bus:AuditExempt-NoAccountantsReport 2019-02-01 2020-01-31 05341925 2019-01-31 05341925 uk-bus:OrdinaryShareClass1 2019-02-01 2020-01-31 05341925 uk-bus:OrdinaryShareClass2 2019-02-01 2020-01-31 05341925 uk-bus:OrdinaryShareClass3 2019-02-01 2020-01-31 05341925 uk-bus:PreferenceShareClass1 2019-02-01 2020-01-31 05341925 uk-bus:PreferenceShareClass2 2019-02-01 2020-01-31 05341925 uk-bus:PreferenceShareClass3 2019-02-01 2020-01-31 05341925 uk-core:ShareCapitalPreferenceShares 2020-01-31 05341925 uk-core:ShareCapitalPreferenceShares 2019-01-31 iso4217:GBP xbrli:shares

Registered Number 05341925

NUTRACEUTICAL INGREDIENT CO., LIMITED

Dormant Accounts

31 January 2020

NUTRACEUTICAL INGREDIENT CO., LIMITED Registered Number 05341925

Balance Sheet as at 31 January 2020

2020 2019
£ £
Called up share capital not paid
100000
100000
Net assets
100000
100000
Issued share capital
100000 Ordinary Shares of £ 1 each 100000 100000
Total Shareholder funds
100000
100000

STATEMENTS

  1. For the year ending 31 January 2020 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 10 February 2020

And signed on their behalf by:
Ruiqing FAN, Director